CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Efficacy and Safety of Telbivudine as First-Line Therapy in Patients With Compensated Chronic Hepatitis B
DOI 10.1055/s-0035-1551757
Bibliografische Angaben
Nachweis in CareLit
Autor:innenW Vogel, H Laferl, G Plankensteiner, M Nitzlader
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Chronic hepatitis B (CHB) is a global health problem, with more than 350 million people worldwide infected with hepatitis B virus. Telbivudine, a synthetic thymidine nucleoside analogue, is effective for the treatment of patients with CHB. Methods: This was a non-interventional, observational study conducted in Austria. Treatment of patients with telbivudine (Sebivo®) was in accordance with the actual…
Zitieren
Zitierempfehlung
W Vogel, H Laferl, G Plankensteiner, M Nitzlader (2015) Efficacy and Safety of Telbivudine as First-Line Therapy in Patients With Compensated Chronic Hepatitis B. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0035-1551757
Mit CareLit weiterarbeiten